Elenco degli articoli con argomento «alopecia areata»

Dermatologia

24 mag 2024

Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata

Alopecia areata (AA) is an autoimmune disorder that affects the hair follicles, resulting in patchy recurrent hair loss

25 mar 2024

Alopecia areata: Line-field confocal optical coherence tomography

Alopecia areata: Line-field confocal optical coherence tomography

25 mar 2024

Long-term efficacy and safety of baricitinib in patients with severe alopecia areata

Efficacy of the Janus kinase (JAK) inhibitor baricitinib for severe alopecia areata (AA)

16 gen 2024

Questionario di laboratorio nell'alopecia areata

Questa indagine mira a valutare la pratica dei dermatologi riguardo all'uso di test di laboratorio nell'alopecia areata. I risultati saranno utilizzati per informare la pratica clinica e le linee guida.

19 dic 2023

Effect of baricitinib in patients with alopecia areata

Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation

24 nov 2023

Un aggiornamento per te da EADV 2023 navigation-next-alternate

Inibitori di JAK nelle indicazioni dermatologiche

23 nov 2023

When to expect scalp hair regrowth during treatment of severe alopecia areata

Baricitinib is approved for the treatment of adults with severe alopecia areata (AA)

31 ott 2023

Induced hair loss

This article discusses drug-induced hair loss

13 giu 2023

Impact and Management of Loss of Eyebrows

Eyelashes and eyebrows have different functions, ranging from practical purposes such as protecting the eye apparatus from external hazards

20 feb 2023

A Review on the Safety of Using JAK Inhibitors in Dermatology

Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions

03 feb 2023

Survey Alopecia Areata navigation-next-alternate

Studio per valutare l'approccio diagnostico e terapeutico nei pazienti affetti da Alopecia Areata

23 gen 2023

Systematic review of newer agents for the management of alopecia areata

Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments suitable for long-term use

21 nov 2022

Treatment of pediatric alopecia areata

Alopecia areata (AA) is an autoimmune, nonscarring hair loss disorder with slightly greater prevalence in children than adults.

08 nov 2022

COVID-19 vaccination and alopecia areata

Coronavirus disease 2019 (COVID-19) is a major concern worldwide and various vaccines have been developed and approved

08 giu 2022

Alopecia legata ai trattamenti antitumorali navigation-next-alternate

Questo opuscolo ha lo scopo di aiutarla a comprendere meglio l’alopecia e i cambiamenti dei capelli

11 ott 2021

Phase 2a randomized clinical trial of dupilumab

Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited

26 lug 2021

Treatment of pediatric alopecia areata

Alopecia areata (AA) is an autoimmune, nonscarring hair loss disorder with slightly greater prevalence in children than adults

15 lug 2020

Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages.

The skin as a neuroendocrine organ and the role of neuroendocrine signaling in the development of disorders affecting the skin and its appendages has received increasing attention in the last years.

15 giu 2020

The Alopecia Areata Consensus of Experts (ACE) study

Results of an international expert opinion on treatments for alopecia areata

10 mag 2020

Alopecia totalis and universalis long‐term outcomes: a review

Alopecia totalis (AT) and universalis (AU) represent the most severe subtypes of alopecia areata with more dramatic features and worse prognosis